Nicorandil-induced peripheral vasodilatation during cardiopulmonary bypass

Annals of Thoracic Surgery

Volumn 67, Issue 4, 1999, Pages 1158-1159

  Falase, Bode A ^a   Bajaj, Balwinder S ^a   Wall, Tracey J ^a   Argano, Vincenzo ^a   Youhana, Aprim Y ^a  

^a MORRISTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; AMLODIPINE; AMOXICILLIN; ANTIANGINA PECTORIS AGENT; ATENOLOL; ATORVASTATIN; BISOPROLOL; DIGOXIN; DILTIAZEM; ENALAPRIL; FUROSEMIDE; HEPARIN; INOTROPIC AGENT; ISOSORBIDE 5 NITRATE; NICORANDIL; NORADRENALIN; PHENYLEPHRINE; PRAVASTATIN; TRANDOLAPRIL; VASOCONSTRICTOR AGENT;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; DRUG ACTIVITY; HUMAN; HYPOTENSION; OPEN HEART SURGERY; PRIORITY JOURNAL; VASODILATATION;

ADMINISTRATION, ORAL; CARDIOPULMONARY BYPASS; HUMANS; HYPOTENSION; NICORANDIL; RETROSPECTIVE STUDIES; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0032964259     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00132-0     Document Type: Article

References (3)

1. Kato K. Haemodynamic and clinical effects of an intravenous potassium channel opener - a review. Eur Heart J. 14:(Supp B):1993;40-47.
2. Montgomery H., Sumeray M., Carr C., Singer M. Sinus arrest and severe peripheral vasodilatation following cardiopulmonary bypass in a patient taking Nicorandil. Cardiovasc Drugs Ther. 11:1997;81.
3. Witchitz S, Darmon JY. Nicorandil safety in the long-term treatment of coronary heart disease. Cardiovasc Drugs Ther 1995;9(Suppl 2):2:237-43.